Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S7W-01710 · Session 7

What discussions it has had with the Department of Health and Social Care regarding encouraging manufacturers to submit a licensing applica…

Answered Asked by Andrew Baxter LD Lodged 15 Jul 2026

The question

To ask the Scottish Government what discussions it has had with the Department of Health and Social Care regarding encouraging manufacturers to submit a licensing application for the ACT-O-VIAL hydrocortisone system.

The answer

Answered by Maree Todd on 10 Aug 2026 · 26 days after it was lodged, on time

The Scottish Government has not had any direct discussions with the Department of Health and Social Care (DHSC) regarding encouraging manufacturers to submit a licensing application for the ACT-O-Vial hydrocortisone system and other similar products, as medicines regulation and licensing are reserved matters.The decision to market a product in the UK rests with the pharmaceutical company. Neither the MHRA nor the UK or Scottish Governments can compel a pharmaceutical company to seek a marketing authorisation for, or supply, a product in the UK market.The Solu-Cortef Act-O-Vial® 100 mg/2 mL injection is not licensed in the UK but may be supplied as an unlicensed imported medicine through specialist importers where clinically appropriate. Community pharmacists wishing to obtain this product are required to seek approval from their Health Board before ordering an unlicensed import.

In the Official Report

No contribution in the Official Report cites S7W-01710 by reference.